Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

Special Report

NeurologyLive Peer Exchange

Medcast

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Expert Authors

FDA News

Features

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Job Board

Live Events

Neurology Resources

Virtual Events

Subscribe

Videos

The neurologist at Duke Health provided insights on how chronic demyelinating inflammatory polyneuropathy treatment is evolving toward biomarker-driven, personalized approaches at the 2025 Carolina Neuromuscular Summit. [WATCH TIME: 2 minutes]

The Shift in CIDP Treatment Toward Individualized, Evidence-Based Care: Karissa Gable, MD

Articles

Teva's fremanezumab gains FDA approval for pediatric migraine prevention, offering a vital treatment option for children aged 6-17.

FDA Approves Fremanezumab as First Anti-CGRP Preventive Therapy for Pediatric Episodic Migraine

The chief scientific officer at Alzheon discussed the mechanism of valiltramiprosate and new data on toxic amyloid oligomers presented at the recently concluded Alzheimer’s Association International Conference.

NeuroVoices: John Hey, PhD, on Alzheimer Agent Valiltramiprosate and Its Promise in Mild Cognitive Impairment

The Harold I. Nemuth Chair in Neurological Disorders at Virginia Commonwealth University discussed new data supporting the potential of GLP-1 RAs as a non-surgical option for idiopathic intracranial hypertension. [WATCH TIME: 3 minutes]

Exploring GLP-1 Receptor Agonists for Idiopathic Intracranial Hypertension: Dennis Rivet, MD

, has been with the team since September 2022. Follow her on Twitter 

The advisory board member of the Parkinson's Foundation shared personal insights on how love, present-moment awareness, and hope shaped her approach to living with the Parkinson disease. [WATCH TIME: 6 minutes]

Prescription of Love, Mindfulness, and Hope in Parkinson Disease Care: Esther Labib-Kiyarash, MSHA, CPHQ

Associate vice president of strategy and innovation at the National MS Society.

At CMSC 2025, Cassandra Moore, MPH, CPH, associate vice president of strategy and innovation at the National MS Society, discussed the impact of health and wellness coaching in patients with multiple sclerosis. 

Reviewing the Power of Health and Wellness Coaching in Multiple Sclerosis Care

The director of neurosurgical pain division at Allegheny General Hospital highlighted the push to intervene earlier with neurosurgical treatments for chronic pain, including diabetic neuropathy. [WATCH TIME: 4 minutes]

Rethinking When to Refer for Pain Surgery: Nester Tomycz, MD

The associate professor of neurology at Icahn School of Medicine at Mount Sinai discussed the clinical and scientific advantages of blood-based biomarkers over imaging for Alzheimer disease. [WATCH TIME: 5 minutes]

Debating on the Clinical Utility of Blood-Based Biomarkers for Alzheimer Diagnosis: Fanny Elahi, MD, PhD

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

LinkedIN

YouTube

Spotlight

AAIC 2025

CMSC 2025

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

News Network

1rem

View

Allegheny Health Network

SAP Partners

Click below for the latest updated from Allegheny Health Network's Neuroscience Institute: 

At Allegheny Health Network (AHN), compassion and innovation meet. We bring together groundbreaking procedures, advanced technology, and the latest research to create new models of care that provide exceptional health care.

We’re focused on creating world-class, affordable health care close to home. In the last year or two, we’ve added more than 20 new facilities across western Pennsylvania. These include five new cancer centers, four neighborhood hospitals, expanded emergency departments at Saint Vincent and Jefferson hospitals, and a fifth Health + Wellness Pavilion.

And, we’ve opened a new 160-bed hospital in Wexford, as well as expanded our facilities at Allegheny General Hospital to house the new AHN Cancer Institute Academic Center.
With more than 200 active construction projects, we’re committed to improving access and quality of our services in the region.

The difference we make in the lives of our patients and their communities is #LivingProof.

SAP Partner

NOINDEX

NOFOLLOW

"Brainwaves" Latest from AHN Neuroscience Institute

"Brainwaves" Latest from AHN Neuroscience Institute

Newsletter